Speak Up for COPD
The SPEAK UP FOR COPD campaign is intended to raise awareness and understanding of COPD amongst policymakers and healthcare decision makers by amplifying the voices...
Read more
What have we learnt from real-life research in asthma and COPD? Standards and novel designs for the future
The Observational & Pragmatic Research Institute (OPRI) is proud to announce a new publication, ”What have we learnt from real-life research in asthma and...
Read more
The Observational & Pragmatic Research Institute (OPRI) warmly welcomes the Singapore Severe Asthma Registry (SSAR) to the International Severe Asthma Registry (ISAR)!
Established by a partnership between Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), Changi General...
Read more
You wouldn’t think twice about asking your asthma patients to quit smoking, but have you ever asked them whether they have allergic rhinitis?
You wouldn’t think twice about asking your asthma patients to quit smoking, but have you ever asked them whether they have allergic rhinitis? Not such a strange...
Read more
OPRI is excited to share a milestone in asthma phenotype recognition!
OPRI is excited to share a milestone in asthma phenotype recognition! The ISAR #publication titled, ”Eosinophilic and Non eosinophilic Asthma, An Expert...
Read more
Are severe asthma patients getting the right treatment?
Are severe asthma patients getting the right treatment? Research has shown that you can’t take a one-size-fits-all approach to severe asthma management due to...
Read more
DDL 2021 Virtual Conference
In this video, DDL Invites Professor David Price to speak in the DDL 2021 Virtual Video Conference, Professor Price explains the changes in GINA asthma management and...
Read more
We are delighted to share a new #podcast, “Improving the status quo – can severe asthma be better treated?” on @The Spectator Briefings!
We chat about the experiences of Gabby Perry, a student with severe #asthma, and the dual-edged swords that are steroids. Along with Gabby, Syed Ali, medical affairs...
Read moreCONQUEST quality standards: for the COllaboratioN on QUality improvement initiative for achieving Excellence in STandards of COPD care
The CONQUEST Quality Standards (QS) aim to enhance care for COPD patients at a higher, yet modifiable, risk of COPD exacerbations, increased morbidity and mortality...
Read more
Evaluating the impact of targeted, risk-based management in patients with modifiable high-risk COPD
The Observational and Pragmatic Research Institute is proud to announce the launch of the Pragmatic Evaluation of an Improvement Program for People Living with...
Read more
COVID-19 Quality Improvement Programme for Primary Care
New COVID-19 quality improvement programme available to GP practices across the United Kingdom First-of-its-kind quality improvement programme to exclusively focus on...
Read more
Using systemic steroids to manage asthma
Bleecker ER, Menzies-Gow A, Price D, Bourdin A, Sweet S, Martin A, Alacqua M, Tran TN. Systematic Literature Review of Systemic Corticosteroid Use for Asthma...
Read more
Improving patient care for children with asthma: PeARL’s first steps
Mathioudakis AG, Custovic A, Deschildre A, Price D et al. Research priorities in pediatric asthma: Results of a global survey of multiple stakeholder groups by the...
Read more
Aiding physicians in prescribing the right inhaler
World-leading Singapore research institute, the Observational Pragmatic Research Institute (OPRI), is the largest contributor to the global understanding of inhalers...
Read more
Management of Asthma in Different Phenotypes – Presented at APSR 2019
Professor David Price recently spoke about the management of asthma in different phenotypes at the Asian Pacific Society of Respirology’s Asthma Symposium 2019. While...
Read more
Inhaled Corticosteroids In COPD And Onset Of Type 2 Diabetes And Osteoporosis: A Matched Cohort Study
A study by OPRI published in NPJ Primary Care Respiratory Medicine found a link between ICS therapy for patients with COPD and the onset of type 2 diabetes and...
Read more
Describing the GOLD Group Distribution and Appropriateness of Therapy in Patients with COPD.
A study by OPRI describing in details the GOLD group distribution in patients with COPD who started their initial treatment and those with established COPD has been...
Read more
Leveraging Randomized Clinical Trials to Generate Real-World Evidence for Regulatory Purposes
Washington, 11th July 2019 – Professor David Price, head of The Observational & Pragmatic Research Institute (OPRI; Singapore) and Optimum Patient Care (OPC...
Read more
Management of Community-Acquired Pneumonia: An Observational Study in UK Primary Care
A study to assess the frequency of CRB65 scoring in patients diagnosed with community-acquired pneumonia (CAP) in primary care has been recently published in the Dove...
Read more
Omalizumab in the Era of Precision Medicine
Allergic allergy has been increasing in Hong Kong given evolutionary and genetic or environmental factors. Omalizumab, or anti-IgE, is a monoclonal antibody approved...
Read more
Primary Care Respiratory Society Conference 2019 🗓
The PCRS Respiratory Conference is the UK’s leading respiratory conference. Its aim is to inspire delegates to discover new ways of working with patients and...
Read more
Boehringer Ingelheim and Optimum Patient Care Launch First US Primary Care Patient Registry to Improve COPD Care and Outcomes
First-of-its-kind registry to exclusively focus on chronic obstructive pulmonary disease (COPD) treatment by primary care physicians Registry will track 3,000...
Read more
Could heart drug help lung disease patients?
Drugs traditionally used to treat blood pressure and heart disease are to be given to lung disease patients to see if they can be beneficial, in a trial coordinated...
Read more
Adding low dose theophylline to inhaled corticosteroids does not reduce COPD exacerbations
A CRN supported Respiratory Disorders trial (TWICS), which investigated whether taking a low-dose theophylline tablets in addition to inhaled corticosteroids would...
Read more
Does changing inhaler device change asthma outcomes?
Singapore, 5th October 2018. Most people with asthma rely on inhaled asthma medication to control their symptoms. Inhaler devices are available as either dry powder...
Read more
Predictive utility of database-derived asthma exacerbation and asthma control measures in a UK primary care database
Database-derived measures of asthma control was predictive of asthma treatment response and future asthma exacerbation. This study validates the usage of database...
Read more
COPD patient subset gains no benefit from low-dose theophylline
AT ATS 2018 SAN DIEGO – For people with COPD at high risk of exacerbation, the addition of low-dose theophylline to inhaled corticosteroids conferred no overall...
Read more
Hay fever sufferers may not be picking the right drugs to treat symptoms
A study in The Journal of Allergy and Clinical Immunology: In Practice found the majority of surveyed people with hay fever were not picking optimal over-the-counter...
Read more